Tevogen Bio Holdings Inc. (NASDAQ: TVGN)
$1.2900
N/A ( +1.58% ) 826.8K
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.